|
1
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 (Suppl 7):vii320–vii325. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Joko R, Yamada D, Nakamura M, Yoshida A,
Takihira S, Takao T, Lu M, Sato K, Ito T, Kunisada T, et al: PRRX1
promotes malignant properties in human osteosarcoma. Transl Oncol.
14(100960)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tian W, Li Y, Zhang J, Li J and Gao J:
Combined analysis of DNA methylation and gene expression profiles
of osteosarcoma identified several prognosis signatures. Gene.
650:7–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hirokawa N and Tanaka Y: Kinesin
superfamily proteins (KIFs): Various functions and their relevance
for important phenomena in life and diseases. Exp Cell Res.
334:16–25. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Camlin NJ, McLaughlin EA and Holt JE:
Motoring through: The role of kinesin superfamily proteins in
female meiosis. Hum Reprod Update. 23:409–420. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Samejima K, Samejima I, Vagnarelli P,
Ogawa H, Vargiu G, Kelly DA, de Lima Alves F, Kerr A, Green LC,
Hudson DF, et al: Mitotic chromosomes are compacted laterally by
KIF4 and condensin and axially by topoisomerase IIα. J Cell Biol.
199:755–770. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mazumdar M, Sung MH and Misteli T:
Chromatin maintenance by a molecular motor protein. Nucleus.
2:591–600. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xue D, Cheng P, Han M, Liu X, Xue L, Ye C,
Wang K and Huang J: An integrated bioinformatical analysis to
evaluate the role of KIF4A as a prognostic biomarker for breast
cancer. OncoTargets Ther. 11:4755–4768. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631.
2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Matsumoto Y, Saito M, Saito K, Kanke Y,
Watanabe Y, Onozawa H, Hayase S, Sakamoto W, Ishigame T, Momma T,
et al: Enhanced expression of KIF4A in colorectal cancer is
associated with lymph node metastasis. Oncol Lett. 15:2188–2194.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang
Y, Deng L, Lu Q and Luo S: FOXM1 promotes hepatocellular carcinoma
progression by regulating KIF4A expression. J Exp Clin Cancer Res.
38(188)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Namløs HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One.
7(e48086)2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cates JM: Simple staging system for
osteosarcoma performs equivalently to the AJCC and MSTS systems.
Journal of orthopaedic research : official publication of the
Orthopaedic Research Society. 36:2802–2808. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mu J, Fan L, Liu D and Zhu D:
Overexpression of shugoshin1 predicts a poor prognosis for prostate
cancer and promotes metastasis by affecting epithelial-mesenchymal
transition. OncoTargets Ther. 12:1111–1118. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Narayan G, Bourdon V, Chaganti S,
Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider
A, Pothuri B, et al: Gene dosage alterations revealed by cDNA
microarray analysis in cervical cancer: Identification of candidate
amplified and overexpressed genes. Genes Chromosomes Cancer.
46:373–384. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gao J, Sai N, Wang C, Sheng X, Shao Q,
Zhou C, Shi Y, Sun S, Qu X and Zhu C: Overexpression of
chromokinesin KIF4 inhibits proliferation of human gastric
carcinoma cells both in vitro and in vivo. Tumour Biol. 32:53–61.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Minakawa Y, Kasamatsu A, Koike H, Higo M,
Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H,
et al: Kinesin family member 4A: A potential predictor for
progression of human oral cancer. PLoS One.
8(e85951)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zou JX, Duan Z, Wang J, Sokolov A, Xu J,
Chen CZ, Li JJ and Chen HW: Kinesin family deregulation coordinated
by bromodomain protein ANCCA and histone methyltransferase MLL for
breast cancer cell growth, survival, and tamoxifen resistance. Mol
Cancer Res. 12:539–549. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pan J, Lei X and Mao X: Identification of
KIF4A as a pan-cancer diagnostic and prognostic biomarker via
bioinformatics analysis and validation in osteosarcoma cell lines.
PeerJ. 9(e11455)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mazumdar M, Sundareshan S and Misteli T:
Human chromokinesin KIF4A functions in chromosome condensation and
segregation. J Cell Biol. 166:613–620. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu G, Lu Y, Li L, Jiang T, Chu S, Hou P,
Bai J and Chen M: The kinesin motor protein KIF4A as a potential
therapeutic target in renal cell carcinoma. Invest New Drugs.
38:1730–1742. 2020.PubMed/NCBI View Article : Google Scholar
|
